Shares of Merck & Co. Inc. MRK inched 0.08% higher to $99.45 Tuesday, on what proved to be an all-around favorable trading ...

The year 2024 saw the U.S. stock market make new records, with major indices breaching key milestones. While many stocks ...

In connection with the start of the phase 3 trials of PCV21, Sanofi has expanded its alliance with South Korea-based SK Bio, ...

For some years industry observers have been asking what Merck & Co can do to reduce its reliance on blockbuster cancer immunotherapy Keytruda. Now, it seems a key part of that effort will come ...

The Chronicle of Philanthropy released its annual list of the biggest charitable gifts from individuals or foundations this ...

The global market for barrett’s esophagus with dysplasia treatment is poised for significant growth, with a projected ...

Merck (MRK) closed the most recent trading day at $99.45, moving +0.08% from the previous trading session. The stock fell short of the S&P 500, which registered a gain of 1.1% for the day. Meanwhile, ...

The global market for community acquired bacterial pneumonia (CABP) treatment is expected to experience robust growth over ...

U.S. Enters a New Political Era, Defined by Donald Trump The presidential race in 2012 ended a pattern in U.S. politics, which has since become characterized by Mr. Trump’s populism, a Times ...

Two neighbouring housing developments proposing to build 54 flats between them will offer just three parking spaces, it has emerged. A prolific thief targeted the same shop not once, not twice ...

Speaking on his Formula For Success podcast, which he co-hosts with David Coulthard, Jordan said: 'We've kind of alluded to it David, over the shows. Way back in March and April, I was diagnosed ...